Five Prime Therapeutics Inc. said its CFO and senior vice president, Marc Belsky, resigned to pursue another opportunity.
Belsky will continue in his current role until April 6.
The South San Francisco, Calif.-based cancer drug developer plans to start a search for a new CFO immediately.
